G A Marbet

1.9k total citations
62 papers, 1.4k citations indexed

About

G A Marbet is a scholar working on Hematology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, G A Marbet has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 17 papers in Surgery and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in G A Marbet's work include Blood Coagulation and Thrombosis Mechanisms (17 papers), Venous Thromboembolism Diagnosis and Management (13 papers) and Hemophilia Treatment and Research (11 papers). G A Marbet is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (17 papers), Venous Thromboembolism Diagnosis and Management (13 papers) and Hemophilia Treatment and Research (11 papers). G A Marbet collaborates with scholars based in Switzerland, United States and Germany. G A Marbet's co-authors include F Duckert, Dimitrios A. Tsakiris, Fritz R. Bühler, F Burkart, B. E. Lütold, Markus Küng, Matthias Pfisterer, Martin Tschöpl, Dimitrios Α. Tsakiris and Bernhard Lämmle and has published in prestigious journals such as Gastroenterology, Biochemical and Biophysical Research Communications and The Journal of Infectious Diseases.

In The Last Decade

G A Marbet

60 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G A Marbet Switzerland 21 422 373 335 284 210 62 1.4k
Thomas Vukovich Austria 21 440 1.0× 356 1.0× 257 0.8× 181 0.6× 254 1.2× 32 1.2k
J. W. J. van Wersch Netherlands 23 266 0.6× 185 0.5× 372 1.1× 299 1.1× 152 0.7× 88 1.5k
C. Conri France 19 314 0.7× 344 0.9× 171 0.5× 190 0.7× 268 1.3× 62 1.5k
Kaj Anker Jørgensen Denmark 23 369 0.9× 198 0.5× 145 0.4× 146 0.5× 75 0.4× 72 1.6k
Elina Vahtera Finland 19 415 1.0× 253 0.7× 495 1.5× 501 1.8× 185 0.9× 57 1.9k
E. Wenzel Germany 22 351 0.8× 264 0.7× 427 1.3× 266 0.9× 157 0.7× 110 1.5k
Martti Syrjälä Finland 19 202 0.5× 224 0.6× 358 1.1× 296 1.0× 78 0.4× 49 1.2k
G. R. Fearnley United Kingdom 24 277 0.7× 237 0.6× 374 1.1× 446 1.6× 89 0.4× 65 1.7k
C. Harold Mielke United States 19 379 0.9× 508 1.4× 515 1.5× 201 0.7× 225 1.1× 36 1.5k
Raúl Altman Argentina 17 305 0.7× 686 1.8× 158 0.5× 157 0.6× 341 1.6× 53 1.2k

Countries citing papers authored by G A Marbet

Since Specialization
Citations

This map shows the geographic impact of G A Marbet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G A Marbet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G A Marbet more than expected).

Fields of papers citing papers by G A Marbet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G A Marbet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G A Marbet. The network helps show where G A Marbet may publish in the future.

Co-authorship network of co-authors of G A Marbet

This figure shows the co-authorship network connecting the top 25 collaborators of G A Marbet. A scholar is included among the top collaborators of G A Marbet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G A Marbet. G A Marbet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marbet, G A, et al.. (2008). Unexpected Bleeding following Eyelid Tumor Resection leading to the Rare Diagnosis of Acquired Haemophilia. Klinische Monatsblätter für Augenheilkunde. 225(5). 424–426. 5 indexed citations
2.
3.
Meili, Esther, et al.. (2001). Ribavirin and interferon alpha-2b combination treatment of chronic hepatitis C is effective in patients with clotting disorders. Gastroenterology. 120(5). A382–A383. 6 indexed citations
4.
Tsakiris, Dimitrios Α., et al.. (1995). Anticardiolipin antibodies do not seem to be associated with APC resistance in vivo or in vitro. Annals of Hematology. 71(4). 195–198. 5 indexed citations
5.
Close, Philippe, J. Bichler, Roger Kerry, et al.. (1994). Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).. PubMed. 5(11). 943–9. 33 indexed citations
6.
Tsakiris, Dimitrios Α., et al.. (1994). ENDOTHELIN IN THE EARLY PHASE OF BONE MARROW TRANSPLANTATION. Transplantation. 57(2). 300–300. 7 indexed citations
7.
Reymond, Marc A., et al.. (1992). Aspirin as a risk factor for hemorrhage in patients with head injuries. Neurosurgical Review. 15(1). 21–25. 56 indexed citations
8.
Tsakiris, Dimitrios A., et al.. (1991). [Profibrinolytic activity of recombinant hirudin?].. PubMed. 121(10). 338–40. 1 indexed citations
9.
Meier, Patricia Stutzmann, et al.. (1990). Patterns of contact phase proteins indicating neuropathy in diabetic patients. Annals of Hematology. 61(4). 222–225. 1 indexed citations
10.
Reusser, P, W. Zimmerli, D. Scheidegger, et al.. (1989). Role of Gastric Colonization in Nosocomial Infections and Endotoxemia: A Prospective Study in Neurosurgical Patients on Mechanical Ventilation. The Journal of Infectious Diseases. 160(3). 414–421. 97 indexed citations
11.
Verhaeghe, Raymond, P Besse, Henri Bounameaux, & G A Marbet. (1989). Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis. Thrombosis Research. 55(1). 5–11. 37 indexed citations
12.
Tsakiris, Dimitrios Α., et al.. (1989). Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant. Thrombosis and Haemostasis. 61(2). 175–177. 57 indexed citations
13.
Marbet, G A, et al.. (1988). Detection of small inhibitory effects of acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole blood. Thrombosis Research. 51(1). 55–62. 22 indexed citations
14.
Fritschi, J, et al.. (1984). The Contact Phase of Blood Coagulation in Diabetes Mellitus and in Patients with Vasculopathy. Thrombosis and Haemostasis. 52(3). 221–223. 15 indexed citations
15.
Marbet, G A, et al.. (1984). Fibrinogen, factor VIII related antigen, antithrombin III and alpha 2-antiplasmin in peripheral arterial disease.. PubMed. 52(3). 240–2. 19 indexed citations
16.
Theiss, W, F Asbeck, G Trübestein, et al.. (1983). Systemic Fibrinolytic Activity and Inhibitor Levels During Treatment of Deep Vein Thrombosis with Urokinase and Streptokinase. Thrombosis and Haemostasis. 50(3). 664–668. 4 indexed citations
17.
Marbet, G A, F Duckert, L Biland, et al.. (1982). Sequential Treatment of Arterial Occlusions with Porcine Plasmin and Low Dose Streptokinase. Thrombosis and Haemostasis. 48(2). 187–189. 5 indexed citations
18.
Marbet, G A, et al.. (1980). Reactivity of a Hereditary Abnormal Antithrombin III Fraction in the Inhibition of Thrombin and Factor Xa. Thrombosis and Haemostasis. 44(2). 92–95. 15 indexed citations
19.
Marbet, G A. (1980). FULL DOSE HEPARINISATION RATHER BY CONTINUOUS OR DISCONTINUOUS HEPARIN INFUSION OR BY SUBCUTANEOUS ADMINISTRATION. Scandinavian Journal of Haematology. 24(S36). 112–125. 1 indexed citations
20.
Bühler, Fritz R., F Burkart, B. E. Lütold, et al.. (1975). Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. The American Journal of Cardiology. 36(5). 653–669. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026